The latest news from academia, regulators
research labs and other things of interest
Posted: March 3, 2009
Fluidigm Sells Record Numbers of Systems and IFC Chips in 2008
(Nanowerk News) Fluidigm announced that its instrument and integrated fluidic circuit (IFC) sales reached record levels in 2008. Volumes of both BioMark™ instruments and Fluidigm chips more than doubled when compared to 2007.
“In the first half of 2008 we basically matched our prior year’s level of product sales. In the second half our sales accelerated to new levels,” said Gajus Worthington, Fluidigm president and chief executive officer. “While the worldwide economy declined in the third and fourth quarters of last year, demand for Fluidigm products dramatically increased. Interest in our products soared during the final six months of the year and our sales tracked that trajectory.”
The Pharma sector of the life science industry proved to be a strong growth segment for Fluidigm during 2008. More than a half-dozen pharmaceutical companies, including Medimmune, Novartis and others adopted or expanded their use of Fluidigm IFC technology last year.
The use of IFCs in the Ag-Bio (Agriculture – Biology) sector also exploded as Alaska Department of Fish and Game and ENZA shifted high-throughput programs to high gear. Bayer CropScience business operations unit BioScience and its global vegetable seed specialist Nunhems, as well as the Columbia River Inter-Tribal Fish Council brought Fluidigm technology into their organizations.
Top research centers worldwide, such as Boston University; Cancer Research UK Centre for Genetic Epidemiology, The University of Cambridge; The Children's Hospital, Boston - a Harvard Medical School Affiliate; Cukurova University – Turkey; The Institute of Biotechnology of Prague; Keio University; LGC; Nano Gen Teknolojileri, National Measurement Institute in Australia and others joined the growing ranks of IFC users tackling some of the most challenging health, medical and life science issues of the day.
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm’s IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These “integrated circuits for biology” are made possible by miniaturizing and integrating liquid handling components on a single microfabricated device (chip). Fluidigm’s IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.
For more information, please visit www.Fluidigm.com.